Clinical Study on the Melarsoprol-Related Encephalopathic Syndrome: Risk Factors and HLA Association

Melarsoprol administration for the treatment of late-stage human African trypanosomiasis (HAT) is associated with the development of an unpredictable and badly characterized encephalopathic syndrome (ES), probably of immune origin, that kills approximately 50% of those affected. We investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Seixas, Jorge, Atouguia, Jorge, Josenando, Teófilo, Vatunga, Gedeão, Miaka Mia Bilenge, Constantin, Lutumba, Pascal, Burri, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157710/
https://www.ncbi.nlm.nih.gov/pubmed/31906333
http://dx.doi.org/10.3390/tropicalmed5010005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157710/
https://www.ncbi.nlm.nih.gov/pubmed/31906333
http://dx.doi.org/10.3390/tropicalmed5010005

Ejemplares similares